Related references
Note: Only part of the references are listed.Histone H1.3 Suppresses H19 Noncoding RNA Expression and Cell Growth of Ovarian Cancer Cells
Magdalena Medrzycki et al.
CANCER RESEARCH (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial Carcinoma
C. Blake Gilks et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
ER+/PR+/TFF3+/IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases
Paulette Mhawech-Fauceglia et al.
HISTOPATHOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Pair-Box (PAX8) protein-positive expression is associated with poor disease outcome in women with endometrial cancer
P. Mhawech-Fauceglia et al.
BRITISH JOURNAL OF CANCER (2012)
Pure Compared With Mixed Serous Endometrial Carcinoma Two Different Entities?
Thijs Roelofsen et al.
OBSTETRICS AND GYNECOLOGY (2012)
Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning
Yuriko Mori et al.
ENDOCRINE-RELATED CANCER (2011)
Clinical management of uterine papillary serous carcinoma
Thijs Roelofsen et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Gene Expression Profiles in Stage I Uterine Serous Carcinoma in Comparison to Grade 3 and Grade 1 Stage I Endometrioid Adenocarcinoma
Paulette Mhawech-Fauceglia et al.
PLOS ONE (2011)
IMP3 Distinguishes Uterine Serous Carcinoma From Endometrial Endometrioid Adenocarcinoma
Paulette Mhawech-Fauceglia et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Minor Serous and Clear Cell Components Adversely Affect Prognosis in Mixed-Type Endometrial Carcinomas: A Clinicopathologic Study of 36 Stage-I Cases
M. Ruhul Quddus et al.
REPRODUCTIVE SCIENCES (2010)
Utility of p16 Expression for Distinction of Uterine Serous Carcinomas From Endometrial Endometrioid and Endocervical Adenocarcinomas Immunohistochemical Analysis of 201 Cases
Anna Yemelyanova et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R
Heidi Dvinge et al.
BIOINFORMATICS (2009)
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)
Amanda Nickles Fader et al.
GYNECOLOGIC ONCOLOGY (2009)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: Similar outcomes belie distinctive biologic differences
Robert A. Soslow et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
HOMER2 binds MYO18B and enhances its activity to suppress anchorage independent growth
Rieko Ajima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1
N Berteaux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Endometrial cancer: Socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival
T Madison et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2004)
Hormonal regulation of H19 gene expression in prostate epithelial cells
N Berteaux et al.
JOURNAL OF ENDOCRINOLOGY (2004)
An analysis of the impact of pathology review in gynecologic cancer
S Chafe et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
